CLINICAL EFFICACY OF KASAHARA DASHEMANI GRANULES ON COUGH

A CRITICAL ANALYSIS ON KASAHARA DASHEMANI OF CHARAKA SAMHITA

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017598

Enrollment

Registered

2019-02-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R05- Cough

Interventions

Intervention1: KASAHARA DASHEMANI GRANULES: KASAHARA DASHEMANI IN THE FORM OF GRANULES OF DOSE 12 GRAMS(1 KARSHA) IN THREE DIVIDED DOSES AFTER FOOD FOR 7 DAYS Control Intervention1: NOT APPLICABLE: NO

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS FULFILLING THE DIAGNOSTIC CRITERIA OF COUGH (KASA) AS PER CLASSICAL TEXT. PATIENTS FROM 18 TO 60 YEARS OF EITHER SEX.

Exclusion criteria

Exclusion criteria: KSHATAJA AND KSHAYAJA KASA DIABETIC MELLITUS, OTHER SYSTEMIC DISORDERS AND MEDICATION THAT INTERRUPT THE STUDY. PREGNANT AND LACTATING WOMEN.

Design outcomes

Primary

Measure	Time frame
THE EFFICACY OF INTERVENTION ON SUBJECTIVE CRITERIA(SCORING ON SIGNS & SYMPTOMS) OF COUGH.Timepoint: 1 WEEK	—

Secondary

Measure	Time frame
THE EFFICACY OF INTERVENTION BASED ON OBJECTIVE CRITERIAS(LAB INVESTIGATIONS)Timepoint: 2 WEEKS	—

Countries

India

Contacts

Public ContactDR SHALINI H E

GOVERNMENT AYURVEDA MEDICAL COLLEGE

dr.shreevathsa@rediffmail.com9901958968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026